Ultimately, the in vivo experiments demonstrated that overexpression of SNORD113-3 or ADAR2, as well as knockdown of PHKA2, effectively suppress the development of GBM in vivo and enhance the survival outcomes of mice harboring GBM. The gene discussed is PHKA2; the disease is glioblastoma.